Chief Operating Officer
Konstantin Fiedler joined Foundation Medicine, Inc. in November 2016 as general manager of international markets. He brings with him more than a decade of global leadership experience at world-renowned companies, including, Linde Group, Danaher and General Electric.
Prior to joining Foundation Medicine, Inc., Fiedler was head of innovation at Linde Healthcare, Germany where he led the development of medical devices, hospital efficiency solutions, and innovative business models to better manage chronic diseases at home. During his time, he served as a board member of HealthXL, a digital health accelerator located in Dublin, Ireland.
He joined Linde from Danaher, where he was a member of the global executive team of Leica Biosystems division serving as vice president, Advanced Staining. There, he led the global Tissue Diagnostics business unit, located in the U.K. and Australia and, during his tenure, expanded the product portfolio towards Class III devices and the regional footprint by opening a companion diagnostics development facility in the U.S.
Before this, Fiedler was member of the Global Executive of Life Sciences division at General Electric where he held numerous leadership roles at various business units within the company, including, integration leader for Clarient; general manager, cell technologies & growth initiatives and general manager, protein analysis for GEHC Life Sciences; head of business development for GEHC Protein Separations and director, portfolio analysis for GE Healthcare. Earlier in his career he held senior positions at Amersham plc and SmithKline Beecham.
Fiedler earned his Ph.D. from the University of Konstanz, Germany and his MS in Physics from the University of Graz, Austria.